Magovern James A, Singh Deepak, Teekell-Taylor Leah, Scalise Deborah, McGregor Walter
Department of Cardiovascular and Thoracic Surgery, Allegheny General Hospital, Pittsburgh, PA 15212, USA.
ASAIO J. 2007 May-Jun;53(3):316-9. doi: 10.1097/MAT.0b013e31804b19f7.
Postoperative inflammatory response is common in heart surgery patients, but less is known about variation in the baseline inflammatory state. This study characterizes the preoperative inflammatory profile in a group of high- and low-risk patients (n = 32; male 16, female 16; mean age, 70.3 +/- 1.8) and relates this to postoperative events. Interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, TNF receptors (R1 and R2), and high-sensitivity C-reactive protein were measured before surgery and 4 hours after arrival in the intensive care unit. Considerable variability existed in all preoperative inflammatory mediators before surgery. Patients with an elevated baseline IL-6 level, (IL-6 >10 pg/mL) were older (73.5 +/- 2.2 vs. 67.9 +/- 2.6 years), had a lower ejection fraction (34 +/- 3.8% vs. 44 +/- 2.9%), a higher predicted risk score (10.3 +/- 1.2 vs. 5.9 +/- 1.1), and a higher baseline high-sensitivity C-reactive protein (65 +/- 10 vs. 24 +/- 6 mg/L), p < 0.05 for all. These patients had high morbidity and mortality rates after surgery. In addition, patients judged to be at high risk on clinical criteria were found to have consistent elevations in the baseline inflammatory state. All patients had a surge in inflammatory mediators after surgery, but those who started at a higher baseline reached a higher postoperative level than the others (IL-6 2023 +/- 561 vs. 361 +/- 47 pg/mL, p < 0.05). Many heart surgery patients, especially higher-risk patients, have a significant inflammatory state before surgery. These patients are at risk for high morbidity and mortality rates after surgery.
术后炎症反应在心脏手术患者中很常见,但对于基线炎症状态的差异了解较少。本研究对一组高风险和低风险患者(n = 32;男性16例,女性16例;平均年龄70.3±1.8岁)的术前炎症特征进行了描述,并将其与术后情况相关联。在手术前以及进入重症监护病房4小时后,检测了白细胞介素-6(IL-6)、肿瘤坏死因子(TNF)-α、TNF受体(R1和R2)以及高敏C反应蛋白。术前所有炎症介质均存在相当大的变异性。基线IL-6水平升高(IL-6>10 pg/mL)的患者年龄更大(73.5±2.2岁对67.9±2.6岁),射血分数更低(34±3.8%对44±2.9%),预测风险评分更高(10.3±1.2对5.9±1.1),基线高敏C反应蛋白更高(65±10对24±6 mg/L),所有比较p均<0.05。这些患者术后发病率和死亡率较高。此外,根据临床标准判断为高风险的患者在基线炎症状态方面持续升高。所有患者术后炎症介质均有激增,但那些基线水平较高的患者术后达到的水平高于其他患者(IL-6 2023±561对361±47 pg/mL,p<0.05)。许多心脏手术患者,尤其是高风险患者,术前存在显著的炎症状态。这些患者术后有高发病率和死亡率的风险。